Internal Medicine News - Zetia, with fenofibrate, approved
Zetia (ezetimibe) has received an expanded approval in combination with diet and fenofibrate for the reduction of total cholesterol and low-density-lipoprotein cholesterol in patients with mixed hyperlipidemia. In the pivotal study, Zetia 10 mg was administered with 160 mg fenofibrate. For more information, please visit www.zetia.com.
Related Results
ZetiaZetia tabletsVytorin and Zetia fail in heart studyZetia, Vytorin come under fireVytorin gaining market share without sapping Zetia
COPYRIGHT 2006 International Medical News Group
COPYRIGHT 2008 Gale, Cengage Learning
